People with severe allergies know it: EpiPens are an essential medicine that saves lives. So if you purchased an EpiPen between August 24, 2011 and November 1, 2020, the drug manufacturer may award you part of a large settlement.
The $264 million class action settlement is the result of a 2017 lawsuit alleging price fixing by Mylan, the maker of EpiPen. If you’re a long-time EpiPen user, you’ll probably remember that the price of the product has steadily increased over time, which has taken a heavy toll on patients’ wallets.
In 2007, an EpiPen prescription cost $100. By 2016, the price had skyrocketed to $608.
Lawsuit plaintiffs allege Mylan worked with pharmaceutical giant Pfizer artificially increase the price of EpiPens.
“The defendants devised an unlawful scheme to monopolize the market for epinephrine self-injection devices”, the lawsuit claims. “As a result, millions of Americans who rely on this life-saving device have paid exorbitant prices for EpiPens that are in no way bound or constrained by a competitive market.”
The EpiPen contains a pre-measured dose of epinephrine, a powerful synthetic hormone. Instead of drawing the drug into a syringe, users simply press the “pen” against their body, triggering a needle that comes out and invisibly injects the drug.
Epinephrine helps buy time in the event of a life-threatening allergic reaction. Users still need emergency medical attention, but epinephrine helps relax the muscles of the airways as the reaction sets in.
Drug manufacturer Pfizer agreed to pay $345 million in a class action settlement opened to claims last year. Now, Mylan has not admitted wrongdoing in its response to the price-fixing lawsuit, but the company has agreed to pay the $264 million settlement.
If you think you are entitled to part of the settlement, you can visit EpiPenClassAction.com and file a complaint. The site notes that if you have already submitted a proof of claim for the Pfizer settlement, you do not need to submit another one now – you will automatically be included as a member of the Mylan settlement.
There are some caveats – people who work for one of the drug companies involved are excluded from the class, for example – but many consumers who have purchased an EpiPen or its generics can join.
Making a claim only takes a few minutes. You do not have to provide proof of purchase immediately, although you may be asked to provide documentation in the future.
The final approval hearing for the settlement is set for July 6. The amount that individuals can receive has not yet been determined. (It depends on how many customers join the costume.)
Customers have until July 25 to submit a claim. If you’re an EpiPen patient, add your name to the class and get a receipt!